Popular on eTradeWire
- Stephanie Peppers Launches Rethread Chronicles - 185
- Cozy Up with Adirondack Fragrance Farm's New Soy Wax Melts - 127
- History Matters: Book Recommendations for September 2024 - 124
- Allegiant Management Group Launches New Website Following Recent Rebranding - 110
- Mounts Botanical Garden to Present RIBBIT THE EXHIBIT II with 18 Larger-Than-Life Frog Sculptures - 106
- Atlas Elite Entertainment Releases New Single "Forever"
- Wagoner Roofing Launches New Website
- Beyond Wellness Chiropractic Voted Best Chiropractor in Charleston for 2024
- Colony Ridge Welcomes A Second DG Market!
- Title Alliance Announces Strategic Consolidation of their Arizona Joint Ventures to Enhance Business
Similar on eTradeWire
- Hypothesis by Richard H. Davis: Carrier Pigeons and Milk Immunity
- IGC Pharma Wins 2 Awards in Phase 1 of NIA's AI PREPARE Challenge, Advancing Alzheimer's Early Prediction Research
- Terumo Blood and Cell Technologies and Nova Biomedical collaborate on automated cell culture sensing
- AI Team from "PersonalAIze" Expert Assessment; Groundbreaking AI Platform Starting with Early Cancer Detection: Renovaro; Stock Symbol: RENB
- Bioasis Announces Resignation of Board of Directors
- Elevation Strategic Development, LLC Expands with New Subsidiary and Enhanced Service Offerings
- NRx Pharmaceuticals NRXP: Prominently Featured in Psychiatrist.com; Article Titled "How NRx Could Upend the Fight Against Depression and Suicide"
- Creative Biolabs presents codes ruling antibody discovery
- Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
- Logical Biological appoints Stephane Argivier as new CEO
Partners4Access to Present Three Poster Abstracts at ISPOR EU 2024
eTradeWire News/10779735
Partners4Access (P4A), a leading global consultancy specializing in market access for orphan drugs, gene therapies, and rare disease treatments, is excited to announce that three of its poster abstracts have been accepted for presentation
LONDON - eTradeWire -- Partners4Access (P4A), a leading global consultancy specializing in market access for orphan drugs, gene therapies, and rare disease treatments, is excited to announce that three of its poster abstracts have been accepted for presentation at the upcoming ISPOR EU 2024 conference, one of the most prominent global events for health economics and outcomes research (HEOR). The conference will take place in Barcelona, Spain, from 17th - 20th November.
The accepted poster abstracts cover critical topics in the evolving landscape of gene therapy, cost-effectiveness analysis, and payer perceptions, showcasing P4A's dedication to advancing knowledge in these crucial areas of healthcare. The titles of the accepted posters are as follows:
"We are thrilled to have our research recognized at ISPOR EU 2024," said Sophie Schmitz, Managing Partner at Partners4Access. "These studies reflect our ongoing commitment to addressing the critical challenges in market access for innovative therapies, and we look forward to sharing our findings with the global HEOR community."
More on eTradeWire News
Partners4Access invites conference attendees to visit their posters to learn more about these important studies and engage in discussions with the research team.
About Partners4Access
Partners4Access (P4A) is a specialized global consultancy focused on providing market access, pricing, and reimbursement solutions for orphan drugs, cell and gene therapies, and other rare disease treatments. With a mission to improve patient access to life-changing therapies, P4A works closely with pharmaceutical and biotech companies to navigate the complex landscape of rare diseases, ensuring successful market entry and sustainable patient access.
For more information, visit www.partners4access.com.
The accepted poster abstracts cover critical topics in the evolving landscape of gene therapy, cost-effectiveness analysis, and payer perceptions, showcasing P4A's dedication to advancing knowledge in these crucial areas of healthcare. The titles of the accepted posters are as follows:
- What Are the Key Themes and Sentiments Captured through Social Listening in Response to Recent Changes in the Duchenne Muscular Dystrophy Treatment Landscape?
- This poster delves into the insights gathered from social listening to understand the key themes and sentiments among stakeholders following recent developments in the treatment options for Duchenne Muscular Dystrophy.
- The Key to Success for Estimating Durability in Cost-Effectiveness-Focused Markets
- This research explores the methodologies and challenges in estimating the durability of new therapies, particularly in markets where cost-effectiveness is a primary consideration for payer decision-making.
- Payer Perceptions of Supportive Evidence in the Estimation of Long-Term Durability for Gene Therapies in Major European Markets
- This poster presents findings on how payers in major European markets perceive the evidence supporting the long-term durability of gene therapies, offering insights into the factors that influence reimbursement decisions.
"We are thrilled to have our research recognized at ISPOR EU 2024," said Sophie Schmitz, Managing Partner at Partners4Access. "These studies reflect our ongoing commitment to addressing the critical challenges in market access for innovative therapies, and we look forward to sharing our findings with the global HEOR community."
More on eTradeWire News
- Hempex.com Launches USDA Organic Hemp Seed Oil, Expanding USDA Organic Hemp Product Line
- Vatican synod is opening the door a bit wider for Catholic women − Are Women Interested?
- Inherit the Wind at North Coast Repertory Theatre Reading Series
- ALLTRA SmartChain Partners with Kryptobox.io to Enhance Global Digital Asset Accessibility
- ALLTRA SonicSwap Expands DeFi Opportunities with Weekly Listings and Global Partnerships
Partners4Access invites conference attendees to visit their posters to learn more about these important studies and engage in discussions with the research team.
About Partners4Access
Partners4Access (P4A) is a specialized global consultancy focused on providing market access, pricing, and reimbursement solutions for orphan drugs, cell and gene therapies, and other rare disease treatments. With a mission to improve patient access to life-changing therapies, P4A works closely with pharmaceutical and biotech companies to navigate the complex landscape of rare diseases, ensuring successful market entry and sustainable patient access.
For more information, visit www.partners4access.com.
Source: Partners 4 Access
Filed Under: Biotech
0 Comments
Latest on eTradeWire News
- TopFan Helps Associations Strengthen Membership Engagement with a Customizable Fan Club Platform
- Mend Colorado Promotes One-on-One, Science-Based Personal Training in Boulder with New Webpage
- NCAA Eliminates National Letter of Intent Program: Implications for Canadian Athletes
- Lawsuit Dropped; Abortion Safe, But Only For Now
- Multinational energy group TEDOM acquires Italian cogeneration leader Intergen
- Bethany Nikitenko Appointed to Board of Directors of Philadelphia VIP
- Wm. F. Ross Special Mini Train Inaugural Run 10/19 at The National Museum of Transportation
- Benchmark International Faciltd Between Storm Guardian Generators, LP & NorthCurrent Partners, LLC
- Individual Winners and Company Finalists for GCOI 2024 Announced by the Arizona Technology Council and Arizona Commerce Authority
- DTC Computer Supplies Announces Name Change to DES Technologies
- Robert Maloy Announces Candidacy for City Council in Windcrest
- Arkansas Hose Pro Celebrates Successful First Year with Fleet Expansion
- Holabird's timed, online-only Cauldron of Curiosities auction, October 19-20, features numismatics, Western Americana, more
- One Of The Largest Native American Burial Sites In The United States Moves A Step Closer To National Recognition
- Support CCAE Foundation's Continued Leadership of California Center for the Arts
- 2024 ASA Litigation in Valuation Conference to Focus on Winning Strategies for High-Stakes Cases
- Online Traffic For Insurance Agents Grows Significantly As AEP Approaches
- SBAC Onboards New Board and Loan Committee Members
- The National Lottery Heritage Fund award £3.5 million to support Linkage Weelsby Hall development
- Join ASA's Winter Fair Value Conference for Insights into Evolving Standards and Best Practices